Dexamethasone, Intravenous Injection of Human Immunoglobulin, and Increased Infusion of Mononuclear Cells to Reduce Donor Specific Antibodies in Haploidentical Hematopoietic Stem Cell Transplantation

NCT07698080 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Lymphoma
Thalassemia
Aplastic Anemia
Myelodysplastic Syndromes

Interventions

BIOLOGICAL: Intravenous Immunoglobulin
DRUG: Dexamethasone
BIOLOGICAL: Mononuclear Cells

Sponsor

Hematology department of the 920th hospital